NDC 76961-101 – Rolvedon
Eflapegrastim 13.2 mg/.6mL · Injection, Solution · Subcutaneous
Product NDC76961-101
Product details
- Brand name
- Rolvedon
- Generic name
- Eflapegrastim-xnst
- Labeler
- Spectrum Pharmaceuticals, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761148
- Marketed since
- October 18, 2022
- Marketing end
- August 31, 2027
- Pharmacologic class
- Leukocyte Growth Factor
Active ingredients
- Eflapegrastim 13.2 mg/.6mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 76961-101-01 | .6 mL in 1 SYRINGE, GLASS (76961-101-01) | Oct 18, 2022 |
Other Rolvedon products
- 82497-132 Eflapegrastim 13.2 mg/.6mL · Injection, Solution · Assertio Specialty Pharmaceuticals, LLC